
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.940 | 0.940 | 0.000 |
Shares | 99.060 | 99.060 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 22.218 | 19.346 |
Price to Book | 3.844 | 2.571 |
Price to Sales | 2.500 | 1.792 |
Price to Cash Flow | 15.715 | 13.285 |
Dividend Yield | 1.851 | 1.833 |
5 Years Earnings Growth | 9.199 | 11.778 |
Name | Net % | Category Average |
---|---|---|
Industrials | 47.260 | 38.918 |
Technology | 13.340 | 12.801 |
Financial Services | 11.490 | 6.564 |
Healthcare | 11.050 | 14.093 |
Consumer Defensive | 7.010 | 5.051 |
Consumer Cyclical | 5.680 | 7.712 |
Real Estate | 2.330 | 10.451 |
Communication Services | 1.840 | 5.226 |
Number of long holdings: 30
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Atlas Copco B | SE0017486897 | 7.70 | 133.8 | +1.75% | |
AstraZeneca | GB0009895292 | 6.97 | 10,134.0 | -3.52% | |
ABB | CH0012221716 | 5.64 | 45.05 | +1.65% | |
Hexagon B | SE0015961909 | 5.51 | 92.64 | +1.58% | |
EQT AB | SE0012853455 | 5.00 | 279.10 | +1.79% | |
Fortnox | SE0017161243 | 4.84 | 86.64 | -0.02% | |
Epiroc A | SE0015658109 | 4.57 | 214.90 | +0.33% | |
Essity B | SE0009922164 | 4.47 | 272.70 | -1.52% | |
AddLife | SE0014401378 | 3.97 | 188.20 | +0.59% | |
Thule Group AB | SE0006422390 | 3.38 | 236.80 | +1.81% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
NO0010923899 | 24.44B | -6.95 | 3.39 | 8.63 | ||
NO0010923915 | 24.44B | -7.01 | 3.13 | 8.36 | ||
NO0010923931 | 24.44B | -7.12 | 2.62 | 7.63 | ||
NO0010923956 | 24.44B | -6.95 | 3.39 | 8.50 | ||
NO0010923782 | 22.75B | -10.20 | 4.50 | 10.43 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review